| ||
| ||
Second Circuit Vacates Pharmaceutical Misbranding Conviction On Free ... Mondaq News Alerts (registration) After two years of deliberation, the U.S. Second Circuit Court of Appeals has finally issued its decision in United States v. Caronia, holding that the government cannot prosecute pharmaceutical manufacturers or their representatives solely for ... See all stories on this topic » | ||
Sun Pharmaceutical gains ground following release of generic cancer drug The Star-Ledger - NJ.com Sun Pharmaceutical Industries Ltd., controlled by Indian billionaire Dilip Shanghvi, rose the most in 14 months after the U.S. approved the company's generic version of Johnson & Johnson's cancer drug Doxil. The U.S. Food & Drug Administration allowed ... See all stories on this topic » | ||
MSF claims aid for vaccines subsidizing pharmaceutical companies, Guardian ... News-Medical.net "Large sums of public money intended to ensure children in the developing world are immunized against disease are effectively being used to subsidize Big Pharma, doctors working in the field claim," the Guardian reports. "Médecins Sans Frontières (MSF) ... See all stories on this topic » | ||
Most Read Pharmaceutical and Health News - January '13 PR Newswire (press release) AUSTIN, Texas, Feb. 5, 2013 /PRNewswire/ -- dailyRx News announced today the most popular health topics viewed and shared during January 2013. dailyRx News publishes and syndicates consumer-centric health information across affiliated websites, ... See all stories on this topic » | ||
China Botanic Pharmaceutical Inc. Announces Receipt Of Notice Of Failure To ... Daily Markets (press release) 5, 2013 /PRNewswire/ — China Botanic Pharmaceutical Inc. (AMEX: CBP) (formerly Renhuang Pharmaceuticals, Inc.) ("China Botanic" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional ... See all stories on this topic » | ||
Catalyst Pharmaceutical Partners to Present at 15th Annual BIO CEO & Investor ... PharmaLive (press release) (subscription) Catalyst Pharmaceutical Partners, Inc. is a specialty pharmaceutical company focused on the development and commercialization of prescription drugs targeting rare (orphan) neurological diseases and disorders, including Lambert-Eaton Myasthenic ... See all stories on this topic » | ||
Research and Markets: Analysis of Teva Pharmaceutical Industries PharmiWeb.com (press release) This complete and comprehensive analysis of Teva Pharmaceutical Industries, includes an overview of the industry the company operates in, a PEST Framework Analysis of the industry, and then moves on to analyzing the company itself. Company analysis ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment